Cancer-related genes such as TP53, BRAF and KRAS are frequently mutated in OC with TP53 mutated in almost all Type II cancers whilst mutations in BRAF and KRAS are more common in borderline ovarian tumours and Type I cancers. This evidence concerns the gene KRAS and cancer.